A pragmatic primary care approach to the patient with significant solar damage

被引:0
作者
Ayesa, Charles [1 ,2 ,3 ,4 ,5 ]
机构
[1] Skin Canc Coll Australasia, Coll Censor, Brisbane, Qld, Australia
[2] Univ Queensland, Fac Hlth Sci, Primary Care Unit, Brisbane, Qld, Australia
[3] Macquarie Univ, MQ Hlth, Sydney, NSW, Australia
[4] SkinSense Clin, Sydney, NSW, Australia
[5] Icon Canc Ctr, Sydney, NSW, Australia
关键词
MODULATED ARC THERAPY; SUNSCREEN APPLICATION; SKIN; SUPPLEMENTATION; DERMATOSCOPY; PREVENTION; DERMOSCOPY; ACCURACY; OUTCOMES;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Australian general practice patients commonly have significant solar damage. This can lead to the manifestation of actinic keratoses (AKs) as discreet lesions or as field disease, with these lesions potentially giving rise to keratinocyte cancers (KCs). Therefore, a pragmatic approach is needed to assess and manage these higher-risk patients. Objective This article discusses an approach to managing patients with significant solar damage from a primary care perspective, focusing on the assessment and treatment of AKs as individual lesions and within a field. Discussion Significant solar damage is typified by the presence of AKs, commonly seen as field disease. Several field treatment modalities are available for patients. Treatment options need to be tailored to the individual patient and site of disease to maximise adherence and efficacy.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 28 条
[1]  
Apotex, 2020, APOC-5FU cream Consumer Medicine Information
[2]   Skin checks in primary care [J].
Arasu, Alexis ;
Meah, Nekma ;
Sinclair, Rodney .
AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2019, 48 (09) :614-619
[3]   Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review [J].
Arcuri, Domenico ;
Ramchatesingh, Brandon ;
Lagace, Francois ;
Iannattone, Lisa ;
Netchiporouk, Elena ;
Lefrancois, Philippe ;
Litvinov, Ivan V. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
[4]  
Cancer Council Australia, 2024, About Sunscreen
[5]  
Clebak KT, 2020, AM FAM PHYSICIAN, V101, P145
[6]  
Cockerell Clay J, 2005, J Drugs Dermatol, V4, P462
[7]  
Cranwell WC, 2017, AUST FAM PHYSICIAN, V46, P270
[8]   Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy [J].
Cunningham, Trevor J. ;
Tabacchi, Mary ;
Eliane, Jean-Pierre ;
Tuchayi, Sara Moradi ;
Manivasagam, Sindhu ;
Mirzaalian, Hengameh ;
Turkoz, Ahu ;
Kopan, Raphael ;
Schaffer, Andras ;
Saavedra, Arturo P. ;
Wallendorf, Michael ;
Cornelius, Lynn A. ;
Demehri, Shadmehr .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (01) :106-116
[9]   A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses [J].
Darlington, S ;
Williams, G ;
Neale, R ;
Frost, C ;
Green, A .
ARCHIVES OF DERMATOLOGY, 2003, 139 (04) :451-455
[10]  
European Medicines Agency, 2020, EMA suspends Picato as a precaution while review of skin cancer risk continues press release